T. Rowe Price Funds SICAV - US Blue Chip Equity Fund Q GBPRegister to Unlock Ratings |
Performance History | 30/09/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 29.7 | 19.7 | -31.7 | 43.1 | 20.6 | |
+/-Cat | -1.5 | -2.2 | -10.2 | 16.4 | 8.0 | |
+/-B’mrk | -2.2 | -7.6 | -8.5 | 11.0 | 2.3 | |
Category: US Large-Cap Growth Equity | ||||||
Category Benchmark: Morningstar US LM Brd Growt... |
Key Stats | ||
NAV 03/10/2024 | GBP 51.81 | |
Day Change | 1.83% | |
Morningstar Category™ | US Large-Cap Growth Equity | |
IA (formerly IMA) Sector | North America | |
ISIN | LU1028172069 | |
Fund Size (Mil) 03/10/2024 | USD 847.41 | |
Share Class Size (Mil) 03/10/2024 | GBP 43.77 | |
Max Initial Charge | - | |
Ongoing Charge 25/09/2024 | 0.82% |
Morningstar Research |
Analyst Report | 07/06/2024 Adam Sabban, Senior Analyst Morningstar, Inc |
The T. Rowe Price Blue Chip Growth strategy, including the John Hancock subadvised fund, exchange-traded fund, separate account, and offshore vehicles, benefits from a deep team and well executed process. It earns Morningstar Analyst Ratings... | |
Click here to read this analyst report on the underlying fund. |
Morningstar Pillars | |
---|---|
People | 24 |
Parent | 25 |
Process | 24 |
Performance | |
Price |
Investment Objective: T. Rowe Price Funds SICAV - US Blue Chip Equity Fund Q GBP |
To increase the value of its shares, over the long term, through growth in the value of its investments. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Paul Greene 01/10/2021 | ||
Inception Date 31/01/2014 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
S&P 500 (Net of 30% withhg tax) | Morningstar US LM Brd Growth NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for T. Rowe Price Funds SICAV - US Blue Chip Equity Fund Q GBP | 31/08/2024 |
|
|
Top 5 Holdings | Sector | % |
Microsoft Corp | Technology | 9.64 |
Apple Inc | Technology | 9.60 |
NVIDIA Corp | Technology | 9.31 |
Amazon.com Inc | Consumer Cyclical | 9.21 |
Eli Lilly and Co | Healthcare | 4.67 |
Increase Decrease New since last portfolio | ||
T. Rowe Price Funds SICAV - US Blue Chip Equity Fund Q GBP |